Drug Identity
Active Ingredient
Tenofovir Disoproxil
Drug Class
Antivirals For Systemic Use
ATC Code
J05AF07
Status
Essential Medicine
What is Hilfovir?
Uses
Monjuvi is used to treat diffuse large B-cell lymphoma (DLBCL ) in combination with lenalidomide that is relapsed or refractory (r/r), or...
How to Take It
Dosage information not available for this product.
Safety Alerts
Before you receive Monjuvi, tell your healthcare provider about all of your medical conditions, including if you: have an active infection or have had one recently are pregnant or plan to become pregnant are breastfeeding or plan to breastfeed
Important Warnings
When treating chronic hepatitis B with tenofovir, monitor liver function tests every 3 months and viral markers for hepatitis B every 3-6 months during treatment (continue monitoring for at least 1 year after discontinuation
recurrent hepatitis may occur on discontinuation), renal or hepatic impairment, hyperphosphataemia
Monitor renal function before treatment, every 4 weeks during first year, then every 3 months
reduce dose or interrupt therapy if serum phosphate or creatinine clearance is decreased
Risk of immune reactivation syndrome in patients with severe immune deficiency within first few weeks or months or starting combination antiretroviral therapy, Risk of osteonecrosis
monitor for signs of joint pain or immobility
Reduced bone mineral density, elderly, Cirrhosis
monitor for hepatic decompensation
Side Effects
Hypophosphataemiareduced bonedensityhyperphosphataemiadizzinessheadacheraised ALT fatiguepancreatitisrashrenal abnormalities lactic acidosisGI disturbance. Rare: Nephrogenic diabetes insipidusproximal renal tubulopathyrenal failure
Drug Interactions
Nephrotoxic drugs
drugs eliminated by active tubular secretion
nucleoside analogues
atazanavir
didanosine
adefovir
tacrolimus. Triple therapy with lamivudine
plus abacavir
Pregnancy & Lactation
Pregnancy
Caution advised, avoid
Lactation
Caution advised, avoid
Price Intelligence
Rs 7,024.18
DRAP approved maximum price · per pack of 30 · approved 22 Jul, 2026
No retail price observed for this pack. Retailers may not exceed the approved maximum.
Prices across sources
DRAPper pack of 30Rs 7,024.18
Should you consider an alternative?
Other options containing Tenofovir Disoproxil, and what they are not.
Identical active ingredient at the same strength. Cheapest per unit first.
Tenofo-B
300Mg
Rs 4,065.9Rs 135.53/unit
Lowest price per unitBelow approved ceilingGETZ PHARMA PAKISTAN
Viread
300mg
Rs 6,557.62
FEROZSONS
Tenovireach
300mg
Rs 7,125.3
No DRAP alertsCCL Pharmaceuticals (Pvt.) Ltd.
Tenfor
300mg
Rs 5,714.8 ceiling
No DRAP alertsRegal Pharmaceuticals
Tenova
300mg
Rs 7,125.44 ceiling
PHARMEVO (PVT) LTD.
Tenovir
300mg
Rs 7,125.3 ceiling
No DRAP alertsCCL Pharmaceuticals (Pvt.) Ltd.
Vireof
300mg
Rs 7,125.3 ceiling
Macter International Limited
Virdal
300mg
Rs 5,177.34 ceiling
No DRAP alertsPharmatec Pakistan (Pvt.) Limited
Scifovir
300mg
Rs 7,024.98 ceiling
No DRAP alertsScilife Pharma Private Limited
Frolot
300mg
Rs 6,881.85 ceiling
No DRAP alertsMartin Dow Limited
Tenofocal
300mg
Rs 6,070.83 ceiling
Caliph Pharmaceuticals (Pvt) Ltd.
Tenfavir
300mg
Rs 6,881.71 ceiling
No DRAP alertsCRYSTOLITE PHARMACEUTICALS
Ordered by lowest price per unit where a pack size is known, then by price. Order is never affected by sponsorship. Not medical advice — confirm any change with your pharmacist or doctor.
For pharma professionalsCompany, market and opportunity intelligence
Company
397
brands
350
molecules
5
alerts